CIK 0001422142
- Non-accelerated filer
- Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547850
- Phone
- +1 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-18 | Cohen Cheryl Director | Grant or award · Stock Option (Right to Buy) | +21,400 | 21,400 | ||
| 2019-06-18 | Prelack Steven Director | Grant or award · Stock Option (Right to Buy) | +21,400 | 21,400 | ||
| 2019-05-14 | HOFFMAN STEPHEN J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +709,050 | 709,050 | ||
| 2019-05-14 | Gardner Joseph H. President | Grant or award · Stock Option (Right to Buy) | +349,350 | 349,350 | ||
| 2019-05-14 | ROGERS MICHAEL W See Remarks | Grant or award · Stock Option (Right to Buy) | +169,500 | 169,500 | ||
| 2019-05-14 | ROGERS MICHAEL W See Remarks | Grant or award · Stock Option (Right to Buy) | +430,500 | 430,500 | ||
| 2019-05-14 | PETERS KEVIN G. See Remarks | Grant or award · Stock Option (Right to Buy) | +63,250 | 63,250 | ||
| 2019-05-14 | PETERS KEVIN G. See Remarks | Grant or award · Stock Option (Right to Buy) | +266,550 | 266,550 | ||
| 2019-04-26 | Novartis Bioventures Ltd 10% owner | Sale | −138,704 | $1.03 | $143K | 4,049,804 |
| 2019-04-25 | Novartis Bioventures Ltd 10% owner | Sale | −563,096 | $1.03 | $580K | 4,188,508 |
| 2019-04-24 | Novartis Bioventures Ltd 10% owner | Sale | −16,403 | $1.03 | $17K | 4,751,604 |
| 2019-04-23 | Novartis Bioventures Ltd 10% owner | Sale | −27,554 | $1.03 | $28K | 4,768,007 |
| 2019-04-22 | Novartis Bioventures Ltd 10% owner | Sale | −7,100 | $0.97 | $7K | 4,795,561 |
| 2019-04-15 | Novartis Bioventures Ltd 10% owner | Sale | −28,794 | $0.99 | $29K | 4,802,661 |
| 2019-04-12 | Novartis Bioventures Ltd 10% owner | Sale | −30,908 | $1.04 | $32K | 4,831,455 |
| 2019-04-11 | Novartis Bioventures Ltd 10% owner | Sale | −57,438 | $1.08 | $62K | 4,862,363 |
| 2019-04-10 | Novartis Bioventures Ltd 10% owner | Sale | −140,230 | $1.09 | $153K | 4,919,801 |
| 2019-04-09 | Novartis Bioventures Ltd 10% owner | Sale | −32,991 | $1.01 | $33K | 5,060,031 |
| 2019-04-08 | Novartis Bioventures Ltd 10% owner | Sale | −27,525 | $1.02 | $28K | 5,093,022 |
| 2019-04-05 | Novartis Bioventures Ltd 10% owner | Sale | −24,661 | $1.02 | $25K | 5,120,547 |
Page 13 of 16 · 312 trades